CENTER ID: | TogoA.00877.b |
ORGANISM: | Toxoplasma gondii ME49 |
ASSOCIATED DISEASE: | Toxoplasmosis |
CURRENT STATUS: | purified |
COMMUNITY REQUEST: | True |
NIH RISK GROUP: | 2 |
SELECT AGENT: | False |
NIH PRIORITY pathogens category: |
IIIB |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
TogoA.00877.b.A2.GE30691 | from TgCentrin2 construct | 74 | 241 |
METHOD | RESULTS |
---|---|
comparative modelling | Robetta_88701 |
RESOURCE | REFERENCE ID |
---|---|
EuPathDB: | ToxoDB:TGME49_250340 |
OrthoMCL: | OG5_138807 |
RefSeq: | XP_002367347.1 |
UniProt: | B6KHM3 |
HARVESTED ON: | data unavailable |
SEQUENCED ON: | 9/28/2010 |
EXPECTED MW: | 21kDa |
OBSERVED MW: | 17kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Too many to count (100+) |
TOTAL EXPRESSION LEVEL: | High Expression |
SOLUBLE EXPRESSION LEVEL | High Expression |
EXPRESSION HOST: | data unavailable |
SEQUENCING RESULT: | pass |
PERCENT IDENTITY: | 100 |
PERCENT COVERAGE: | 100 |